Alkermes plc (NASDAQ:ALKS) Q2 2023 Earnings Conference Call July 26, 2023 8:00 AM ET
Company Participants
Sandra Coombs – Senior Vice President-Corporate Affairs and Investor Relations
Iain Brown – Chief Financial Officer
Todd Nichols – Chief Commercial Officer
Richard Pops – Chief Executive Officer
Conference Call Participants
Chris Shibutani – Goldman Sachs
David Amsellem – Piper Sandler
Paul Matteis – Stifel
Umer Raffat – Evercore ISI
Uy Ear – Mizuho Securities
Marc Goodman – Leerink Partners
Jason Gerberry – Bank of America
Operator
Greetings, and welcome to the Alkermes Second Quarter 2023 Earnings Financial Results Conference Call. My name is Marianne, I’ll be your operator for today’s call. [Operator Instructions] Please note that this conference is being recorded.
I’ll now turn the call over to Sandra Coombs, Senior Vice President of Investor Relations and Corporate Affairs. Sandy, you may begin.
Sandra Coombs
Thank you. Good morning. Welcome to the Alkermes plc conference call to discuss our financial results and business update for the quarter ended June 30, 2023. With me today are Richard Pops, our CEO; Iain Brown, our CFO; and Todd Nichols, our Chief Commercial Officer.
Before we begin, I encourage everyone to go to the Investors section of alkermes.com to find our press release, related financial tables and reconciliations of the GAAP to non-GAAP financial measures that we’ll discuss today. We believe the non-GAAP financial results in conjunction with the GAAP results are useful in understanding the ongoing economics of our business.
Our discussions during this conference call will include forward-looking statements. Actual results could differ materially from these forward-looking statements. Please see Slide 2 of the accompanying presentation, our press release issued this morning and our most recent annual and quarterly reports filed with the SEC for important risk factors that could cause our actual results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise the information provided on this call or in the accompanying presentation as a result of new information or future results or developments. After our prepared remarks, we’ll open the call for Q&A.
And now, I’ll turn the call over to Iain.
Iain Brown
Great. Thank you, Sandy, and hello, everyone. Our second quarter results reflect strong execution across our business, highlighted by the 21% year-over-year growth of our three proprietary commercial products and reinstatement of the long-acting INVEGA royalties in the U.S. following our success in the arbitration with Janssen, which concluded during the quarter.